Search
Dr Nicole Schneider-Daum
Person
Nicole Schneider-Daum studied Food Chemistry at the University of Kaiserslautern. After research visits at the University of Campinas (Unicamp, Brazil) and the University of Murcia (Spain) she graduated [...] in 2004 working on the…
Read more
animal testing in preclinical studies to develop inhaled drugs. A research team led by Dr. Nicole Schneider-Daum of the Department of Drug Delivery across Biological Barriers has succeeded in establishing a [...] a human lung cell line that is…
single hAELVi cell, which we obtained by so-called single cell printing," explains Dr Nicole Schneider-Daum, senior scientist from Lehr's department. "This means that all cells are derived from a single [...] Salhab A., Seipelt R., Urbschat K.,…
Macrophage uptake of cylindrical microparticles investigated with correlative microscopy
Publication
Tscheka C,
Hittinger M,
Lehr C,
Schneider-Daum N,
Schneider M
(2015)
European Journal of Pharmaceutics and Biopharmaceutics, 95, 151-155, 10.1016/j.ejpb.2015.03.010, 25779350
European Journal of Pharmaceutics and Biopharmaceutics, 95, 151-155, 10.1016/j.ejpb.2015.03.010, 25779350
Cell and tissue-based in vitro models for improving the development of oral inhalation drug products
Publication
Hittinger M,
Schneider-Daum N,
Lehr C
(2017)
European Journal of Pharmaceutics and Biopharmaceutics, 118, 73-78, 10.1016/j.ejpb.2017.02.019
European Journal of Pharmaceutics and Biopharmaceutics, 118, 73-78, 10.1016/j.ejpb.2017.02.019
Surface-modified yeast cells: A novel eukaryotic carrier for oral application
Publication
Kenngott E,
Kiefer R,
Schneider-Daum N,
Hamann A,
Schneider M,
Schmitt M,
Breinig F
(2016)
Journal of controlled release : official journal of the Controlled Release Society, 224, 1-7, 10.1016/j.jconrel.2015.12.054, 26763373
Journal of controlled release : official journal of the Controlled Release Society, 224, 1-7, 10.1016/j.jconrel.2015.12.054, 26763373
Ciprofloxacin-loaded PLGA nanoparticles against cystic fibrosis P. aeruginosa lung infections
Publication
Günday Türeli N,
Torge A,
Juntke J,
Schwarz B,
Schneider-Daum N,
Türeli A,
Lehr C,
Schneider M
(2017)
European Journal of Pharmaceutics and Biopharmaceutics, 117, 363-371, 10.1016/j.ejpb.2017.04.032, 28476373
European Journal of Pharmaceutics and Biopharmaceutics, 117, 363-371, 10.1016/j.ejpb.2017.04.032, 28476373
Autologous co-culture of primary human alveolar macrophages and epithelial cells for investigating aerosol medicines. Part I: Model Characterisation
Publication
Hittinger M,
Janke J,
Huwer H,
Scherließ R,
Schneider-Daum N,
Lehr C
(2016)
ATLA Alternatives to Laboratory Animals, 44, 4, 337-347
ATLA Alternatives to Laboratory Animals, 44, 4, 337-347
Autologous co-culture of primary human alveolar macrophages and epithelial cells for investigating aerosol medicines. Part II: evaluation of IL-10-loaded microparticles for the treatment of lung inflammation
Publication
Hittinger M,
Mell N,
Huwer H,
Loretz B,
Schneider-Daum N,
Lehr C
(2016)
Alternatives to laboratory animals : ATLA, 44, 4, 349-360, 27685186
Alternatives to laboratory animals : ATLA, 44, 4, 349-360, 27685186
Advanced in vitro lung-on-chip platforms for inhalation assays: From prospect to pipeline
Publication
Artzy-Schnirman A,
Hobi N,
Schneider-Daum N,
Guenat O,
Lehr C,
Sznitman J
(2019)
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 144, 11-17, 10.1016/j.ejpb.2019.09.006, 31499161
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 144, 11-17, 10.1016/j.ejpb.2019.09.006, 31499161